Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Renal Cell 27Neoplasms 9Kidney Neoplasms 9Carcinoma, Non-Small-Cell Lung 8Carcinoma 7Lung Neoplasms 4Carcinoma, Hepatocellular 4Neoplasm Metastasis 3Colorectal Neoplasms 3Uterine Cervical Neoplasms 2Thyroid Neoplasms 2Stomach Neoplasms 2Solid Tumors 2Parkinson Disease 4, Autosomal Dominant Lewy Body 2Ovarian Neoplasms 2Melanoma 2Kidney Diseases 2Advanced Solid Tumors 2Vulvar Neoplasms 1Vaginal Neoplasms 1Uterine Neoplasms 1Urinary Bladder Neoplasms 1Small Cell Lung Carcinoma 1Skin Neoplasms 1Pancreatic Neoplasms 1Myelodysplastic Syndromes 1Lymphoma, Mantle-Cell 1Liver Diseases 1Leukemia, Myeloid, Acute 1Glioblastoma 1

Interventions

Gemcitabine 13130-nm albumin-bound paclitaxel 10Albumin-Bound Paclitaxel 7Oxaliplatin 4Leucovorin 4Fluorouracil 4Carboplatin 4Paclitaxel 3Cisplatin 3Cetuximab 3Bevacizumab 3pembrolizumab 2napabucasin 2Pemetrexed 2PEGPH20 2MK-4721 2tremelimumab 1relacorilant 1irinotecan sucrosofate 1ensituximab 1durvalumab 1cc-486 1Taxes 1Lead 1Irinotecan 1Enoxaparin 1EC regimen 1Dexamethasone 1CP protocol 1Azacitidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Carcinoma, Pancreatic Ductal × Axitinib × Clear all
NCT00471146 2012-07-16

Study Of Gemcitabine Plus AG-013736 Versus Gemcitabine For Advanced Pancreatic Cancer.

Pfizer

Phase 3 Completed
630 enrolled 13 charts
Gastrointestinal

Carcinoma, Pancreatic Ductal

Data powered by HemOnc (CC BY 4.0) Colophon âš¡